Dako North America, Inc.

Dako North America, Inc. — FDA 510(k) Submissions

Dako North America, Inc. has submitted 4 FDA 510(k) premarket notifications since 2009, of which 4 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Immunohistochemistry Antibody Assay, Estrogen Receptor, Immunohistochemistry Assay, Antibody, Progesterone Receptor . Use the specialty filter in the sidebar to narrow results.